Estimation of Molecular Upper Remission Limit for Monitoring Minimal Residual Disease in Peripheral Blood of Acute Myeloid Leukemia Patients by WT1 Expression
Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2011.363
Full Text
Open PDFAbstract
Available in full text
Date
October 11, 2011
Authors
Publisher
Spandidos Publications